A Phase I Study of R115777 (Zarnestra) in Combination With Induction Chemotherapy in Patients With Newly Diagnosed, High Risk Acute Myeloid Leukemia
Phase of Trial: Phase I
Latest Information Update: 02 May 2013
At a glance
- Drugs Tipifarnib (Primary) ; Cytarabine; Daunorubicin; Etoposide
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 21 Feb 2008 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 21 Feb 2008 Status changed from completed to discontinued as reported by ClinicalTrials.gov.